Avanos Medical (AVNS) Gross Margin (2016 - 2024)
Historic Gross Margin for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to 54.52%.
- Avanos Medical's Gross Margin fell 12300.0% to 54.52% in Q3 2024 from the same period last year, while for Sep 2024 it was 55.51%, marking a year-over-year decrease of 13600.0%. This contributed to the annual value of 56.39% for FY2023, which is 12300.0% down from last year.
- Per Avanos Medical's latest filing, its Gross Margin stood at 54.52% for Q3 2024, which was down 12300.0% from 55.68% recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Gross Margin registered a high of 90.22% during Q4 2021, and its lowest value of 45.98% during Q2 2021.
- Over the past 5 years, Avanos Medical's median Gross Margin value was 55.68% (recorded in 2024), while the average stood at 56.04%.
- As far as peak fluctuations go, Avanos Medical's Gross Margin surged by 434700bps in 2021, and later plummeted by -335600bps in 2022.
- Avanos Medical's Gross Margin (Quarter) stood at 46.76% in 2020, then skyrocketed by 93bps to 90.22% in 2021, then plummeted by -37bps to 56.66% in 2022, then fell by -3bps to 54.82% in 2023, then fell by -1bps to 54.52% in 2024.
- Its Gross Margin stands at 54.52% for Q3 2024, versus 55.68% for Q2 2024 and 57.07% for Q1 2024.